動力新科(600841.SH):正在研發16VK等柴油機產品,以更好地滿足數據中心等領域的市場需求
格隆匯3月24日丨動力新科(600841.SH)在投資者互動平臺表示,公司已開發並投產的12VK柴油機產品適用於商業地產、通訊、工業動力、數據中心等領域,並已開始實現在數據中心的應用案例;目前,公司正在研發16VK等柴油機產品,以更好地滿足數據中心等領域的市場需求。公司合營企業上海菱重發動機有限公司(公司持有其50%的股權)生產的SR系列柴油發動機產品已批量應用於國內地產、數據中心、油田、礦產等高端領域,有關上海菱重發動機有限公司的經營數據詳見公司歷年的年度報告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.